Email:
Media
News Center
Oct. 31
2023
VOLUNTARY ANNOUNCEMENT - BIVALENT COVID-19 mRNA VACCINE (SYS6006.32) OBTAINS CLINICAL TRIAL APPROVAL
Oct. 30
CSPC's GLP-1 Targeted Drug Project Approved as a Major Technology Innovation Project
CSPC's SYHA1813 Research Findings Presented at ESMO
CSPC Wins "Private Enterprises of Scientific and Technological Innovation" Title from ACFIC
Oct. 26
VOLUNTARY ANNOUNCEMENT - NBL-028 FOR THE TREATMENT OF ADVANCED TUMORS OBTAINS CLINICAL TRIAL APPROVAL IN CHINA
Oct. 23
CSPC Included in CPIE 100 for Five Consecutive Years
Contact Us
Phone:
+86 311 8703 7015
Products
Science
About Us
